In a recent study posted to bioRxiv* preprint server, researchers assessed the neutralization efficacy of a self-amplifying ribonucleic acid (saRNA) vaccine targeting severe acute respiratory syndrome ...
Get all the latest news on coronavirus and more delivered daily to your inbox. Sign up here. More than 20,000 people have signed up to voluntarily be exposed to the novel coronavirus in a yet-to-be ...
In their Perspective article (Sept. 9 issue), 1 Rapeport et al. describe their historic SARS-CoV-2 human challenge studies. Challenge models can generate crucial knowledge in this pandemic and in ...